Clinitech Laboratory Ltd
BSE: 544220
₹41.30
₹1.40
(3.51%)
As on 19-Jun-2026IST
Market cap
₹9 Cr
Revenue (TTM)
₹8 Cr
P/E Ratio
22.6
P/B Ratio
--
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
6.4 %
-
ROCE
9.2 %
-
Industry P/E
59.48
-
EV/EBITDA
--
-
Debt to Equity
0
-
Book Value
₹38.7
-
EPS
₹1.7
-
Face value
10
-
Shares outstanding
2,282,400
5 Years Aggregate
CFO
₹0.42 Cr
EBITDA
₹5.09 Cr
Net Profit
₹2.29 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Clinitech Laboratory
| -1.9 | 4.6 | 14.6 | 8.5 | -- | -- | -- |
|
BSE Healthcare
| 10.2 | 1.2 | 12.0 | 10.9 | 24.0 | 14.1 | 12.4 |
|
Company
|
2025
|
|---|---|
|
Clinitech Laboratory
| -46.6 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Clinitech Laboratory
|
41.3 | 9.4 | 8.2 | 0.4 | -- | 6.4 | 22.6 | -- |
| 1,635.8 | 27,424.7 | 2,762.9 | 509.8 | 22.5 | 21.5 | 54.3 | 10.9 | |
| 804.3 | 32,197.2 | 3,904.6 | 239.4 | 13.3 | 11.1 | 133.4 | 14.3 | |
| 531.3 | 1,726.1 | 772.8 | 101.5 | 15.7 | 10.7 | 17 | 1.8 | |
| 552.8 | 11,448.9 | 1,645.9 | 191.2 | 16.2 | 13.3 | 60.3 | 7.6 | |
| 733.8 | 7,365.0 | 755.8 | 67.1 | -- | 13.8 | 95.8 | 6.6 | |
| 316.2 | 1,025.4 | 1,319.3 | -1.5 | -4.5 | 0.3 | 871.9 | 1.6 | |
| 268.4 | 1,395.0 | 310.4 | 31.4 | 17.4 | 13.5 | 43.3 | 5.7 | |
| 540.6 | 8,594.1 | 829.0 | 162.9 | 24.5 | 29 | 52.6 | 14.8 | |
| 1,364.2 | 14,109.2 | 814.2 | 173.0 | 30.1 | 19 | 81.6 | 14.7 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Clinitech Laboratory
--
-
Incorporated
2010
-
Chairman
Jagdish Umakant Nayak
-
Managing Director
Jagdish Umakant Nayak
-
Headquarters
Thane, Maharashtra
-
Website
Looking for more details about Clinitech Laboratory Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Clinitech Laboratory
What is the current share price of Clinitech Laboratory Ltd Today?
The share price of Clinitech Laboratory Ltd is ₹41.30 (BSE) as of 19-Jun-2026 IST. Clinitech Laboratory Ltd has given a return of 8.48% in the last 1 years.
What is the current PB & PE ratio of Clinitech Laboratory Ltd?
The P/E ratio of Clinitech Laboratory Ltd is 22.55 times as on 19-Jun-2026, a 62 discount to its peers’ median range of 59.48 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
23.27
|
1.04
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Clinitech Laboratory Ltd?
The 52-week high and low of Clinitech Laboratory Ltd are Rs 57.00 and Rs 28.55 as of 21-Jun-2026.
What is the market cap of Clinitech Laboratory Ltd?
Clinitech Laboratory Ltd has a market capitalisation of ₹ 9 Cr as on 19-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Clinitech Laboratory Ltd?
Before investing in Clinitech Laboratory Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.